Capricor Therapeutics
Price & Volume
Stats
See more52W Range | $4.30-$40.37 |
Market Cap | $1.6B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $11.1M |
Revenue Growth (YoY) | -7.9% |
Gross Profit (12 Mos) | -$84.4M |
Diluted EPS | -$2.26 |
News
See moreYahoo Finance • 17 days ago
Capricor signals potential commercialization of Deramiocel with $318M cash balance and FDA review milestone
Yahoo Finance • 17 days ago
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 17 days ago
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)
Yahoo Finance • 19 days ago
Sector Update: Health Care Stocks Decline Late Afternoon
About
CEO | Dr. Linda Marbán Ph.D. |
CFO | Mr. Anthony J. Bergmann M.B.A. |
Address | 10865 Road to the Cure, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 231 |
